Chronic Myeloid Leukemia‎

Asciminib Shows Early Promise as Frontline Therapy for CML-CP

By

Jonathan Goodman, MPhil

Publish Date December 19, 2022

Early results appear promising for frontline asciminib in patients with chronic phase chronic myeloid leukemia, according to researchers.

Tyrosine Kinase Inhibitor Discontinuation Safe in Pediatric Chronic Myeloid Leukemia

By

Vicki Moore, PhD

Publish Date September 20, 2022

Researchers sought to determine if discontinuation of TKI therapy was safe for pediatric patients with CML.

Illegitimate Online Pharmacies May Put Cancer Patients at Risk

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date August 4, 2022

Illegitimate online pharmacies are selling imatinib without a prescription, making false claims about being registered with regulatory bodies, and failing to provide patients with drug-related warnings.

Guidelines for CML Not Followed in the Real World

By

John Schieszer

Publish Date June 28, 2022

“Excellent” overall survival is achievable with currently available drugs, according to researchers.

Regular Assessment of Patient-Reported Factors Related to QOL Recommended in Patients With CML

By

Vicki Moore, PhD

Publish Date December 29, 2021

Researchers found relationships between illness uncertainty, self-perceived burden, and quality of life in patients with chronic myeloid leukemia.

Leukemia Clinical Trials

Clinical Trial: Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical trial focusing on the molecular epidemiology of childhood leukemia. Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (CCLS)

Clinical Trial: Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical trial focusing on genetics and chronic lymphocytic leukemia. Genetic Study of Chronic Lymphocytic Leukemia Families

Clinical Trial: Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical trial focusing on vaccine generation from chronic lymphocytic leukemia tumor cells. Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine Generation

Clinical Trial: Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical trial focusing on GNKG168. Phase I Study of GNKG168 in Acute Lymphoblastic Leukemia and Acute Myelogenous Leukemia

Clinical Trial: Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Clinical trial focusing on carfilzomib Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL). Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL) .